Business Standard

Monday, December 23, 2024 | 09:10 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Rossari Biotech tanks 20%, hits 52-week low post December quarter results

The management said raw material volatility has impacted profitability performance during the quarter

Rossari Biotech
Premium

Rossari Biotech

SI Reporter Mumbai
Shares of Rossari Biotech tanked 20 per cent to hit a 52-week low of Rs 915 on the National Stock Exchange (NSE) in Tuesday's intra-day trade after the company reported weak operational performance in December quarter (Q3FY22). The stock of the speciality chemicals has fallen below its previous low of Rs 906.65 touched on February 15, 2021.

In Q3FY22, the company's standalone earnings before interest tax and depreciation and amortization (Ebitda) margin contracted 450 bps at 11.8 per cent from 16.3 per cent in Q3FY21. Profit after tax (PAT) declined 11.5 per cent year-on-year (YoY) at Rs 18.27 crore,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in